A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Belinostat (Primary) ; Isotretinoin
- Indications Solid tumours
- Focus Adverse reactions
- 02 Apr 2018 Status changed from active, no longer recruiting to completed.
- 17 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 10 Jun 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2016.